While the premise of the review is potentially interesting, the justification for focusing on German rehabilitation studies (at the exclusion of studies from outside of Germany) and the rationale for the types of treated diseases to be included would benefit from further elaboration. The authors refer to a) the particulars of insurance authorization in Germany, b) the dearth of RCT studies, and c) a push to strengthen rehabilitation science in Germany based on updated data, as factors motivating the present review. Although a focus on German studies is reasonable, it would helpful to know whether there are any other contextual factors (e.g., cultural differences in patients and/or care) that underscore this focused examination. For example are there any rehabilitationrelated care differences that would make combining with studies in other countries inappropriate? If there are no other reasons than those already presented, would recommend framing the study around rehabilitation care in Germany starting from the first paragraph. At present the authors introduce rehabilitation as a broad challenge across Western countries, which immediately opens up the question why one wouldn't want to cast a broad net that includes other countries. Relatedly, the introduction would benefit from a at least a sentence or two explaining the disease Introduction p. 5, line 21: recommend replacing "implemented by" with "subsidized" or "benefits are provided by". Would recommend a close proofread by a native English speaker as there are grammatical errors throughout the manuscript, many small (e.g., verb tense), but some large that significantly affect the meaning and diminish readability. p. 5, line 43: recommend replacing "and covered for" with "included". This is an example of the type of grammatical error mentioned above.
p. 6, line 12: replace "used" with "included." p. 6, line 16: replace "lead" with "led". From here forward, I will only highlight major grammatical errors that create confusion. Methods p. 6, line 40: The ability to use unpublished studies is not unique to IPD meta-analysis. Investigators conducting a meta-analytic review of aggregate data (AD) can request summary data from unpublished studies. The key advantages of IPD meta-analyses are the increased degree of precision from having the raw data and the ability to tailor the statistical analyses to most appropriately accommodate the features of the data and differences in study design.
p. 8, lines 26 and 29: incorrect verb tenses of "was" and "were" p. 10, line 23: Will data from the treatment arm of RCT trials be included? It's unclear from the description if these studies would be screened out or included. In principle, those should provide the pre-post data the authors are looking for, and the control data could simply be excluded p. 15, line 11: It's stated that the authors of the original studies will be contacted for their original dataset. This is far from a trivial request, and unlikely to get a positive reception despite recent pushes for increased data sharing and transparency. At a practical level, getting access to the original data may often require institutional authorizations beyond a simple "yes" from the study investigator. How will this request process for original data be handled and what steps will be taken to maximize the response rate?
Minimally, it is probably unwise to simply ask for the complete dataset, which is what is implied by asking authors to provide their "original data." Would recommend providing that as an option, as it may be more convenient in some cases (if the study author is authorized to do so), but lead with a focused requested of just the variables of interest.
p. 17, line 6-15: Collapsing treatment arms compromises the original allocation of participants within studies, which threatens the validity of any subsequent conclusions. In the IPD-only analyses, it will not be necessary to collapse multiple treatment arms. There are examples in the literature for how an IPD metaanalysis can be accomplished without collapsing treatment groups (e.g., Huh et. al., 2015 It is unclear if data that is "missing by design" will be treated differently than data missing due to within-study attrition. For example, if a study did not assess outcomes beyond 12 months, will 12-month outcomes be generated in the imputation model? Discussion p. 21, lines 37-39: There will likely be much variation in the timing and length of assessments between studies. For example, many studies will not have follow-ups past 12 months. The authors may want to consider at least one analysis that combines all postintervention assessments (or all post-baseline), as that will permit the inclusion of all of the studies. Otherwise, the studies included in the different analyses (by time point) may vary drastically.
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GENERAL COMMENTS
I think that authors need show more details of the results of metaanalyze. The English level of manuscript need a professional review.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1 This manuscript describes the protocol for a systematic review and meta-analysis of rehabilitation intervention studies in Germany conducted since 1998, focusing on nonrandomized pre-to-post effects of treatment. The proposed study builds on past meta-analytic reviews by utilizing aggregate and individual participant data to estimate overall effects as well as moderators of pre-post change, leveraging more recent data from studies published in the past 10 years.
While the premise of the review is potentially interesting, the justification for focusing on German rehabilitation studies (at the exclusion of studies from outside of Germany) and the rationale for the types of treated diseases to be included would benefit from further elaboration. The authors refer to a) the particulars of insurance authorization in Germany, b) the dearth of RCT studies, and c) a push to strengthen rehabilitation science in Germany based on updated data, as factors motivating the present review. Although a focus on German studies is reasonable, it would helpful to know whether there are any other contextual factors (e.g., cultural differences in patients and/or care) that underscore this focused examination. For example are there any rehabilitation-related care differences that would make combining with studies in other countries inappropriate? If there are no other reasons than those already presented, would recommend framing the study around rehabilitation care in Germany starting from the first paragraph. At present the authors introduce rehabilitation as a broad challenge across Western countries, which immediately opens up the question why one wouldn't want to cast a broad net that includes other countries.
We thank the reviewer for giving us the opportunity to clarify this important issue. One of the main reasons that our review is restricted to rehabilitation care in Germany is that organization, content and case mix of rehabilitation interventions differs widely between countries hampering to interpret summarized effects of rehabilitation interventions between different countries. For example, in Germany, rehabilitation interventions are mostly provided as 3-week or 4-week intensive inpatient interventions in specialized rehabilitations centres. In most other countries, however, rehabilitation interventions are provided as outpatient interventions with a longer duration. Furthermore, rehabilitation centres in Germany have to fulfil intervention standards (intervention guidelines) formulated by the service providers (for example by the German Pension Insurance). Therefore, the variation within Germany is probably smaller than the variation between rehabilitation interventions in other countries. Therefore, summarized effects of studies examining pre-post changes of German rehabilitation interventions can be interpreted as estimate of the expected mean change of a rehabilitation patient in the respective outcome within the German rehabilitation system. A summarized effect of studies including both studies of German rehabilitation system and studies from other countries lacks this clear interpretation. Thus, we think it would be a worthwhile project to compare effects of German rehabilitation interventions with effects of interventions in other countries. However, this question goes behind the purpose of our project.
To clarify this point, we have rewritten the first paragraphs in the introduction as follows:
Rehabilitation is regarded key for health in the 21st century1, but .implementation of rehabilitation interventions varies vastly between countries 2-5. In contrast to outpatient intervention programs in other countries, in Germany, rehabilitation interventions are mostly conducted as 3-week or 4-week inpatient interventions in specialized rehabilitation centres. Rehabilitation is a part of the social insurance system, mostly provided by the German Statutory Pension Insurance (GPI), German statutory health insurances or private health insurances. Certain formal prerequisites provided, a patient is entitled to apply for medical rehabilitation at the GPI, for example. If this application is confirmed by the GPI, the patient has the legal right to get access to a medical rehabilitation program.
These special features of the German rehabilitation systems hamper both, the use of randomized controlled trials (RCTs) to examine the effectiveness of the rehabilitation interventions (though there are a few exceptions6) as well as the comparison with results from RCTs of rehabilitation interventions in other health care systems.
The goal of the present project is to summarize pre-post changes of rehabilitation interventions within the German health care system. To strengthen rehabilitation sciences in Germany, … .
Furthermore, we have rewritten the following sentence in the last paragraph of the discussion section:
Our study may be used to compare the effects observed during rehabilitation interventions in Germany to effects seen in rehabilitation interventions in other health care systems and help to shed more light on the differences between inpatient and outpatient rehabilitation interventions. In summary, we expect our study to have many beneficial effects on research and practice in medical rehabilitation p. 5, line 21: recommend replacing "implemented by" with "subsidized" or "benefits are provided by".
We thank the reviewer for this request. We agree with the reviewer that "implemented by" may be leas to misunderstanding. However, we think that replacing it with "subsidized" or "benefits are provided by" would change the intended meaning of the sentence. We have rewritten the sentence as follows:
Rehabilitation is a part of in the social insurance system, mostly provided by the German Statutory Pension Insurance (GPI), German statutory health insurances or private health insurances.
Relatedly, the introduction would benefit from a at least a sentence or two explaining the disease conditions included in the protocol, since the scope of the review will shape the conclusions on the effectiveness of these types of interventions.
We thank the reviewer for this request. We have included the following sentence in the introduction:
The present study aims to update the previous systematic reviews and expand them to other disease conditions comprising orthopaedics, rheumatology, cardiology, pulmonology, oncology, endocrinology, gastroenterology and psychosomatics
Would recommend a close proofread by a native English speaker as there are grammatical errors throughout the manuscript, many small (e.g., verb tense), but some large that significantly affect the meaning and diminish readability.
We thank the reviewer for this request. We have carefully checked English grammar throughout the whole manuscript.
p. 5, line 43: recommend replacing "and covered for" with "included". This is an example of the type of grammatical error mentioned above
We thank the reviewer for this hint. We have replaced this word as suggested.
p. 6, line 12: replace "used" with "included."
We thank the reviewer for this hint. We have reformulated the sentence as suggested.
p. 6, line 16: replace "lead" with "led".
This has been corrected.
p. 6, line 40: The ability to use unpublished studies is not unique to IPD meta-analysis. Investigators conducting a meta-analytic review of aggregate data (AD) can request summary data from unpublished studies. The key advantages of IPD meta-analyses are the increased degree of precision from having the raw data and the ability to tailor the statistical analyses to most appropriately accommodate the features of the data and differences in study design.
We fully agree with the reviewer. We have rewritten the sentences as follows:
The main advantage of IPD-analyses is that the statistical analyses can be tailored to most appropriately accommodate the features of the data and differences in study design. For example, study specific differences in handling of missing data or study specific approaches of effect size measures can be overcome.
p. 8, lines 26 and 29: incorrect verb tenses of "was" and "were"
We thank the reviewer for this request. We have rewritten the paragraph as follows:
This review and meta-analysis will include literature in English and German language only. We will include studies that started patient recruitment 1998 or later. For the individual participant metaanalysis, we will only include primary studies if they received approval from a competent ethics committee.
p. 10, line 23: Will data from the treatment arm of RCT trials be included? It's unclear from the description if these studies would be screened out or included. In principle, those should provide the pre-post data the authors are looking for, and the control data could simply be excluded.
We thank the reviewer for this remark. We think that there will be no eligible studies that used an RCT with a control group "getting no rehabilitation" for the legal reasons described on page 5 in the manuscript. However, some cohort studies analysing the pre-post effects of a group of patients receiving a rehabilitation program compared to patients receiving no rehabilitation program. From these studies, we will only include data from patients that received the rehabilitation program. We have rewritten the respective sentence as follows:
Studies will be included if data before and after a rehabilitation program (pre-and post-data) on one of the outcomes presented in table 2 have been collected for any disease entity if not otherwise specified.
p. 15, line 11: It's stated that the authors of the original studies will be contacted for their original dataset. This is far from a trivial request, and unlikely to get a positive reception despite recent pushes for increased data sharing and transparency. At a practical level, getting access to the original data may often require institutional authorizations beyond a simple "yes" from the study investigator. How will this request process for original data be handled and what steps will be taken to maximize the response rate? Minimally, it is probably unwise to simply ask for the complete dataset, which is what is implied by asking authors to provide their "original data." Would recommend providing that as an option, as it may be more convenient in some cases (if the study author is authorized to do so), but lead with a focused requested of just the variables of interest.
We agree with the reviewer that getting the original data sets is not a trivial request. We have planned the following steps to get access to the original datasets. First, during the planning stage of our study, we already identified and contacted senior researchers that conducted relevant studies in medical rehabilitation and asked them if they would be willing to provide original datasets for our study in case of funding. Of 14 researchers approached, 14 replied to be willing to share the data. Second, study investigators will be contacted personally (for example at a congress) and by telephone, not only via e-mail. We think that we can handle all questions about the data transfer better in a personal contact. Third, we will provide a list containing all variables we are interested in to the study investigators. We will ask them to send us only the variables matching these constructs. Fourth, we will provide a written agreement to all study investigators (or their institutions, if necessary). In this agreement, we will state that we will use the data only to examine our research questions. Fifth, all investigators who provide data sets will automatically become a member of the scientific advisor board of our project. All members of the advisory board will be informed regularly by e-mail about the progress of the project and will be invited to discuss the results with us. Last, the advisory board will decide at the end of the project whether (and under which circumstances) the combined data set (or parts of it) may be used to examine further research questions (by either our research group or by other researchers).
We have included the following sentences in the respective paragraph:
We will take several steps to ensure the compliance of responsible investigators with our request of accessing original data. First, the primary investigators of the studies will be contacted personally if possible, (for example via telephone), not only via e-mail. Second, we will draft a written agreement that the data will only be used to answer the respective research question. Third, we will inform all investigators who provide original data sets regularly about the progress of the project. Fourth, they will be invited to decide at the end of the project whether (and under which circumstances) the combined data set (or parts of it) may be used to examine further research questions (by either our research group or by other researchers).
p. 17, line 6-15: Collapsing treatment arms compromises the original allocation of participants within studies, which threatens the validity of any subsequent conclusions. In the IPD-only analyses, it will not be necessary to collapse multiple treatment arms. There are examples in the literature for how an IPD meta-analysis can be accomplished without collapsing treatment groups (e.g., Huh et. al., 2015) .
We thank the reviewer for this suggestion. We will do the analyses presented in Huh et al, 2015, as part of our sensitivity analyses. The following sentences were included in the respective paragraph:
However, in a recent study, Huh et al. (2015) presented a statistical model to include more than one intervention arm per study without collapsing the data of the intervention arms. We aim to adopt this approach as part of our sensitivity analyses and will discuss potential differences compared to the primary analyses.
p. 19, lines 25-44: It is unclear if data that is "missing by design" will be treated differently than data missing due to within-study attrition. For example, if a study did not assess outcomes beyond 12 months, will 12-month outcomes be generated in the imputation model?
We thank the reviewer for giving us the opportunity to clarify this important point. We will only impute missing data that should have been available by design. Outcomes that are not assessed in a primary study will not be imputed and included the following paragraph in the section on missing data:
For both AD analyses and IPD analyses, missing data will only be imputed if the data were assessed during the study but were not available for the respective analyses; for example, because data were not reported in AD analyses or specific items or the whole questionnaire was lacking on a given time point for IPD-Analyses. Data were not assessed in the study will not be imputed.
p. 21, lines 37-39: There will likely be much variation in the timing and length of assessments between studies. For example, many studies will not have follow-ups past 12 months. The authors may want to consider at least one analysis that combines all post-intervention assessments (or all post-baseline), as that will permit the inclusion of all of the studies. Otherwise, the studies included in the different analyses (by time point) may vary drastically.
We thank the reviewer for this suggestion. We agree with the reviewer that the number of studies included in the different analyses will probably vary substantially. However, according to our experience, nearly all studies will provide data immediately at the end of the program. Therefore, we hope that we will be able to include all studies when summarizing short-term changes. However, based on previous research (Hüppe & Raspe, 2005) , we expect that pre-post-effects will diminish over time, e.g. we expect lower pre-post effects based on 12-month follow-ups compared to 6-month follow-ups. In our opinion, collapsing both time points into one will be difficult to interpret. Therefore, we would prefer conducting the analyses separately for each measurement occasion.
